Single Use Systems in Biologics Manufacturing and their Impact on Manufacturing Execution System (MES)
Posted on November 8, 2024
Gloria Gadea-Lopez, Ph.D., Advisory Board Member, Carbon Biosciences, Head of Global Consultancy, Business Platforms, (Previously Director of Business Operations Management at Shire)
John Maguire, Director of Manufacturing Sciences, Sanofi, (Previously Associate Director of Manufacturing Systems at Shire)
Since their inception in production, single use systems (SUS) have evolved and improved thanks to the continuous relationship between vendors and biopharmaceutical manufacturers, accommodating a wide range of operational needs. From culture initiation in small volume bags, to large-scale production ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
